This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Is Schwab Fundamental U.S. Small Company Index ETF (FNDA) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNDA
Diversified Healthcare (DHC) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Diversified Healthcare (DHC) closed at $1.94 in the latest trading session, marking a -1.52% move from the prior day.
Is Trending Stock Diversified Healthcare Trust (DHC) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Diversified Healthcare (DHC). This makes it worthwhile to examine what the stock has in store.
Why the Market Dipped But Diversified Healthcare (DHC) Gained Today
by Zacks Equity Research
In the most recent trading session, Diversified Healthcare (DHC) closed at $1.88, indicating a +1.08% shift from the previous trading day.
Diversified Healthcare (DHC) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the latest trading session, Diversified Healthcare (DHC) closed at $2, marking a +1.01% move from the previous day.
Diversified Healthcare (DHC) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
Diversified Healthcare (DHC) closed at $1.88 in the latest trading session, marking no change from the prior day.
Diversified Healthcare (DHC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Diversified Healthcare (DHC) closed at $1.94, marking a +0.52% move from the previous day.
Should Invesco Russell 2000 Dynamic Multifactor ETF (OMFS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for OMFS
Diversified Healthcare Trust (DHC) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Diversified Healthcare (DHC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should Schwab Fundamental U.S. Small Company Index ETF (FNDA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNDA
New Strong Sell Stocks for September 26th
by Zacks Equity Research
ALPMY, ASH and DHC have been added to the Zacks Rank #5 (Strong Sell) List on September 26, 2023.
Diversified Healthcare (DHC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Diversified Healthcare (DHC) closed at $2.31, marking a -0.86% move from the previous day.
Diversified Healthcare Trust (DHC) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Diversified Healthcare (DHC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Diversified Healthcare (DHC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Diversified Healthcare (DHC) closed at $2.26, marking a -1.74% move from the previous day.
Investors Heavily Search Diversified Healthcare Trust (DHC): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Diversified Healthcare (DHC). This makes it worthwhile to examine what the stock has in store.
Is Schwab Fundamental U.S. Small Company Index ETF (FNDA) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNDA
Here is What to Know Beyond Why Diversified Healthcare Trust (DHC) is a Trending Stock
by Zacks Equity Research
Diversified Healthcare (DHC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Diversified Healthcare (DHC) Q2 FFO and Revenues Miss Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of -44.44% and 1.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Diversified Healthcare's (DHC) Q2 Earnings?
by Zacks Equity Research
Positive operating trends in the senior housing operating portfolio and healthy leasing activity in the office portfolio are likely to have aided Diversified Healthcare Trust's (DHC) Q2 performance.
Capital Bancorp (CBNK) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Capital Bancorp (CBNK) delivered earnings and revenue surprises of -8.77% and 0.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Farmland Partners (FPI) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Farmland Partners (FPI) delivered FFO and revenue surprises of -300% and 3.64%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Trending Stock Diversified Healthcare Trust (DHC) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Diversified Healthcare (DHC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Diversified Healthcare (DHC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Diversified Healthcare (DHC) closed at $2.48, marking a -0.2% move from the previous day.
Diversified Healthcare (DHC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Diversified Healthcare (DHC) closed the most recent trading day at $2.69, moving +0.37% from the previous trading session.
Are Finance Stocks Lagging Diversified Healthcare Trust (DHC) This Year?
by Zacks Equity Research
Here is how Diversified Healthcare (DHC) and Manulife Financial (MFC) have performed compared to their sector so far this year.